Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Understanding Expectancies in Cancer Symptom Management…

U.S. National Institutes of Health·United States of America

Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)

Closes 5/7/2026$200k – $500kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

This Notice of Funding Opportunity (NOFO) supports research on expectancy-generating factors and measures of their effects on expectancies and subsequent cancer symptom management outcomes. The research aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Some key points to consider: • The program is particularly interested in applications that enroll individuals and groups from populations historically underrepresented or excluded from biomedical and behavioral research. • Expectancies are defined as beliefs about future outcomes, including one's response to cancer or cancer treatment. • Expectancy effects are the cognitive, behavioral, and biological outcomes caused by expectancies. • The opportunity is open to various types of applicants, including independent school districts, public and state-controlled institutions of higher education, and non-profits.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
8/10/2023
Closes
5/7/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-254

Budget estimate

$200,000 – $500,000

The budget amount for this grant is not explicitly stated in the document. However, based on the information provided, it seems that the grant is intended to support research projects, and the funding amount may vary depending on the scope and complexity of the project. A rough estimate for the budget amount could be in the range of $200,000 to $500,000 per year, considering the typical funding amounts for research grants in the field of healthcare and medical services. However, this is a rough estimate and the actual budget amount may be higher or lower, depending on the specific requirements of the project and the funding available.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 75%

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

74% match

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

74% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024

U.S. National Institutes of Health·United States of America

74% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

73% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

73% match

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Closes 10/19/2027Opened 7/2/2025

U.S. National Institutes of Health·United States of America

72% match

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

72% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

71% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closes 11/6/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

71% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

70% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

70% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

70% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

70% match

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 9/5/2024

U.S. National Institutes of Health·United States of America

70% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

70% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

70% match

DoW Peer Reviewed Cancer, Clinical Trial Award

Rolling / TBD closeOpened 5/6/2026

U.S. National Institutes of Health·United States of America

69% match

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

69% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

69% match

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closes 9/7/2028Opened 11/12/2024

U.S. National Institutes of Health·United States of America

68% match

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/23/2023

U.S. National Institutes of Health·United States of America

68% match

Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Closes 1/7/2028Opened 10/31/2024

U.S. Centers for Disease Control and Prevention - ERA·United States of America

68% match

Pilot Testing, Implementation, and Evaluation of the Cervical, Breast and Colorectal Cancer Clinical Decision Support Tools

Closes 4/21/2027Opened 7/24/2026

U.S. National Institutes of Health·United States of America

68% match

Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)

Closes 11/5/2029Opened 9/29/2025

U.S. National Institutes of Health·United States of America

68% match

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Closes 11/17/2026Opened 12/20/2023